Microbiome-Based Precision Interventions in Type 2 Diabetes Mellitus: Mechanisms, Modulators, and Translational...

Area of Science:

• Metabolic disease research
• Microbiome science
• Precision medicine

Background:

• Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder characterized by insulin resistance, inflammation, and poor glucose regulation.
• Current pharmacological treatments often fail to achieve sustained glycemic control due to individual differences in disease progression and treatment response.

Purpose of the Study:

• To review microbiome-targeted strategies for managing T2DM.
• To explore the role of gut microbiota and its metabolites in T2DM pathogenesis and host regulation.
• To assess the potential of precision medicine approaches in T2DM treatment.

Main Methods:

• Literature review of microbiome-based interventions (probiotics, prebiotics, synbiotics, fecal microbiota transplantation, personalized nutrition).
• Examination of advances in metagenomics and machine learning for biomarker discovery.
• Integration of mechanistic and translational research findings.

Main Results:

• Gut dysbiosis is linked to T2DM through altered microbial metabolites affecting insulin sensitivity, inflammation, and glucose homeostasis.
• Microbiome-targeted strategies offer potential for personalized T2DM management.
• Metagenomics and machine learning are advancing biomarker identification for T2DM.

Conclusions:

• The gut microbiota is a key factor in T2DM development and progression.
• Microbiome-based precision interventions hold significant potential to revolutionize T2DM management.
• Further research integrating mechanistic and clinical insights is needed to implement these strategies effectively.